Status:
UNKNOWN
Investigation of a Polyphenol-rich Preparation as Support for Oncology Patients Undergoing Gastrointestinal Tumor Resection
Lead Sponsor:
AronPharma Sp. z o. o.
Conditions:
Immunomodulation
Eligibility:
All Genders
18-80 years
Phase:
NA
Brief Summary
The aim of the study is to demonstrate, under clinical conditions, the effectiveness of the standard product 'Nutridrink' enriched with a mixture of plant extracts rich in polyphenolic compounds in th...
Detailed Description
Oncology patients undergoing the procedure are exposed to various postoperative complications. Nutridrink with a mixture of extracts with anti-inflammatory and antioxidative properties aims to provide...
Eligibility Criteria
Inclusion
- Women and men, 18-80 years old
- Patients diagnosed with resectable gastrointestinal tract cancer undergo the resection procedure no later than one month after being enrolled in the study
- Signed informed consent
Exclusion
- Intake of supplements containing plant extracts, polyphenols or anthocyanins
- Participation in another clinical trial
- Inability to consume the investigational product in liquid form as medication/placebo
- Women who are pregnant, planning to become pregnant during the study or breastfeeding
- Autoimmune disease, severe liver dysfunction, inflammatory bowel disease, tuberculosis, multiple sclerosis, AIDS, rheumatoid arthritis, organ transplantation
- Hypersensitivity/allergy to any of the ingredient
Key Trial Info
Start Date :
September 1 2023
Trial Type :
INTERVENTIONAL
Allocation :
ESTIMATED
End Date :
December 15 2023
Estimated Enrollment :
30 Patients enrolled
Trial Details
Trial ID
NCT06017661
Start Date
September 1 2023
End Date
December 15 2023
Last Update
September 29 2023
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Uniwersyteckie Centrum Kliniczne, Klinika Chirurgii Onkologicznej, Transplantacyjnej i Ogólne
Gdansk, Poland, 80-214